Sanofi ear­marks €1B for new in­sulin pro­duc­tion fac­to­ry in Bei­jing   

Sanofi has made its sin­gle largest in­vest­ment in Chi­na to date by pour­ing rough­ly €1 bil­lion ($1.05 bil­lion) in­to a new in­sulin man­u­fac­tur­ing fa­cil­i­ty in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.